You spent your 20s figuring out what PCOS actually was. Your 30s managing it. And now, somewhere in your early to mid-40s, something has shifted again — and nobody gave you the script for this part.

Your cycles are changing. Your energy is unpredictable. The brain fog has a new edge to it. Weight is doing something strange no matter what you eat. Anxiety has arrived uninvited and apparently moved in. You're Googling "perimenopause symptoms" at midnight and wondering whether what you're experiencing is your PCOS evolving, perimenopause beginning, or both at once.

This is what I wish someone had told me.

PCOS is a lifelong condition. The way it behaves at 42 is not the same as it did at 22. And if your healthcare team hasn't walked you through what to expect in this life stage — you're not alone, but you deserve better than that.

Here's what's actually happening, what the research shows, and what to do with that information.

PCOS doesn't disappear in your 40s — it shifts from a reproductive condition to a metabolic one, with insulin resistance, blood sugar balance, and cardiovascular health becoming the central concerns.

This is the most important reframe for women with PCOS approaching midlife. The hormonal features that defined your original diagnosis — irregular cycles, elevated androgens, polycystic ovaries — often soften with age. Research shows menstrual cycles in women with PCOS tend to become more regular moving toward perimenopause, and androgen levels gradually decline from the third decade onward.

So in some ways, the reproductive picture improves.

But the metabolic picture is where you need to pay attention.

Insulin resistance — which affects between 65–80% of women with PCOS, regardless of weight — does not resolve with age. When perimenopause arrives and oestrogen levels begin to fluctuate and decline, that existing insulin resistance can accelerate. The Study of Women's Health Across the Nation (SWAN) found that women with PCOS entering perimenopause had significantly higher rates of impaired glucose tolerance compared to women without PCOS — 25% versus 9.2%.

That is not a small difference.

Your body is not failing you. But it is trying to tell you something. And the earlier you listen, the more you can do.

For many women, perimenopause amplifies PCOS-related metabolic symptoms — weight gain, fatigue, blood sugar instability — even when the classic reproductive symptoms of PCOS have eased.

It's complicated, which is exactly why this question trips people up.

In terms of classic PCOS features? Some genuinely improve. Cycle irregularity may stabilise in your late 30s to early 40s. Testosterone levels decline progressively. Ovarian volume reduces. Some women find their most recognisable PCOS symptoms become less pronounced during this period.

But perimenopause brings its own hormonal disruption. Oestrogen fluctuates wildly before it eventually declines. Progesterone drops earlier in the perimenopausal timeline. Both of these changes interact directly with insulin sensitivity, cortisol, mood, sleep, and metabolism.

For a woman with existing insulin resistance, this is a double layer of challenge — and it shows up in very specific ways:

• Stubborn abdominal weight that feels resistant to approaches that used to work
• Blood sugar instability — more pronounced energy crashes, increased sugar cravings, deep afternoon slumps
• Brain fog — a compound effect of oestrogen fluctuation layered onto existing metabolic imbalance
• Anxiety and mood volatility — oestrogen's effect on serotonin, combined with nervous system dysregulation already common in PCOS
• Sleep disruption — often an early perimenopause sign, which then feeds back into cortisol and insulin problems
• Fatigue that doesn't shift — the kind where you sleep eight hours and still feel like you've run a half marathon

You're not imagining it. These experiences are physiologically real and make complete sense when you understand what's happening hormonally.

If this is where you are right now — navigating PCOS and perimenopause at the same time — the challenge is that most products are built for one or the other, not both.

MyOva Menoplus was formulated specifically for this transition. It combines:

• Myo-Inositol + D-Chiro Inositol — the most researched nutrient pairing for PCOS insulin sensitivity and hormonal balance
• Sage leaf (standardised to 4% Rosmarinic Acid) — well-studied for reducing hot flush frequency and severity
• Red Clover isoflavones — phytoestrogens that support oestrogen balance during perimenopausal fluctuation
• Hops extract — evidence for sleep quality and anxiety support
• Shatavari — adaptogenic hormonal support during transition
• Maca root — energy, mood, and libido during hormonal change
• Active B vitamins (Pyridoxal 5'-Phosphate, Methylcobalamin, Calcium L-Methylfolate) — bioavailable forms for mood, nervous system support, and methylation

It's not a magic fix. But it gives your body what it's often missing — a formulation that addresses the PCOS and perimenopausal layers at the same time.

👉 Explore Menoplus →

Standard PCOS diagnostic criteria rely heavily on cycle irregularity and hormone markers that change naturally in perimenopause — which means symptoms are frequently misattributed and the PCOS component gets lost.

This is a problem that even clinicians acknowledge. The Rotterdam criteria — the most widely used diagnostic framework for PCOS — includes irregular menstrual cycles as one of its three core markers. But irregular cycles are also a hallmark of perimenopausal transition. If a woman in her mid-40s arrives at a GP appointment with cycle changes, "perimenopause" becomes the default assumption.

What gets missed: the underlying PCOS has not gone anywhere. The insulin resistance has not resolved. The long-term metabolic risk is still present.

A 2025 study published in Frontiers in Global Women's Health interviewed 29 perimenopausal and postmenopausal women with PCOS and identified a recurring theme researchers named "Déjà vu" — women described the perimenopausal experience as mirroring the confusion and dismissal of their original PCOS diagnosis. They felt, once again, like they were being handed a label without a plan.

If this resonates with you, here is the advocacy point: your PCOS history matters in your perimenopausal care. It should be informing which tests are run, how frequently metabolic markers are monitored, and how treatment decisions are made.

"It's just perimenopause" is not a complete answer for a woman with PCOS. You are allowed to say that clearly.

Women with PCOS face significantly elevated risk of type 2 diabetes, hypertension, and cardiovascular disease during and after perimenopause — risks directly linked to unmanaged insulin resistance.

The research on this is actually pretty clear, and you deserve to hear it plainly.

Type 2 diabetes. Insulin resistance in PCOS increases the risk of impaired glucose tolerance throughout the reproductive years, and that risk rises in perimenopause and beyond. A meta-analysis of 28 studies found women with PCOS had three times the odds of developing type 2 diabetes compared to women without PCOS.

Hypertension. The Dallas Heart Study reported hypertension in 29.2% of women with PCOS versus 18.8% of controls. Chronically elevated insulin damages blood vessel function over time — this is a direct physiological pathway, not a coincidence.

Cardiovascular risk. PCOS is now classified as a cardiovascular disease risk-enhancing factor in its own right. A systematic review found that myocardial infarction and stroke were more prevalent in women with PCOS than controls.

Dyslipidaemia. Present in approximately 70% of PCOS patients, unfavourable cholesterol patterns tend to worsen with ageing and during hormonal transition.

None of this is written to alarm you. Your diagnosis is a starting point, not a verdict — and understanding your actual risk profile is the only way to act on it intelligently. These risks are manageable, significantly so, with the right metabolic strategy.

The women who are most protected in midlife are the ones who stopped treating PCOS as a reproductive inconvenience and started treating it as the whole-body metabolic condition it actually is.

Because PCOS and perimenopause share many symptoms, targeted hormone and metabolic blood testing — not symptom-matching alone — is the most reliable way to understand what's driving what.

This is one of the most common frustrations for women at this life stage. The honest answer is often: both conditions are contributing, and that is physiologically accurate, not a cop-out.

Symptoms that overlap completely:

• Irregular or changing cycles
• Weight gain, particularly abdominal
• Fatigue and energy instability
• Mood changes, anxiety, low mood
• Brain fog
• Sleep disruption
• Reduced libido

What helps differentiate:

Hormone testing at the right time. FSH, LH, oestradiol, testosterone, and AMH are all relevant. Perimenopause is typically characterised by rising FSH and declining oestradiol; PCOS involves LH/FSH ratio imbalance and elevated androgens. But hormonal markers in perimenopause fluctuate enormously — a single test result is rarely the full picture.

Fasting insulin and HbA1c. These are the tests most commonly missed in standard perimenopausal care and the most critical if you have PCOS. They assess insulin resistance directly and reveal the metabolic picture that explains much of what you're experiencing.

Cycle tracking over time. Even imperfect data from three to six months reveals patterns that single appointments cannot.

The practical question to bring to your GP or specialist is not "is this PCOS or perimenopause?" — it's "given my PCOS history, what metabolic monitoring should I have in place, and what does my perimenopausal picture actually look like?"

Women with PCOS approaching perimenopause should focus on insulin sensitivity, strength training, proactive metabolic monitoring, and targeted nutritional support — not just managing symptoms as they arise.

Here's the practical side. These are the areas with the strongest evidence base and the most direct impact on how you feel now and how protected you are long term.

1. Make insulin sensitivity your central focus. This is not about restriction. Insulin resistance is the thread connecting PCOS to perimenopausal metabolic risk. Evidence-backed strategies include protein-forward meals that stabilise blood sugar, reducing ultra-processed carbohydrate load, and building muscle mass — one of the most powerful levers for insulin sensitivity that most women are underusing.

2. Take strength training seriously. Muscle mass is metabolically protective in a way that cardio alone cannot replicate. It improves insulin sensitivity, supports bone density (increasingly important post-40), regulates cortisol, and helps manage body composition during hormonal transition. If your exercise has been predominantly cardio-based, this is the time to rebalance.

3. Monitor the right markers. Standard perimenopausal hormone panels are not sufficient for a woman with PCOS. Ask specifically for: fasting insulin, HbA1c, full lipid panel, blood pressure, and testosterone alongside FSH, LH, and oestradiol. These are not extras — they are the baseline picture you need going into this life stage.

4. Consider targeted nutritional support — particularly inositol. Myo-Inositol and D-Chiro Inositol are among the most researched nutrients for PCOS, with evidence for improving insulin signalling, supporting ovulatory function, and hormonal balance. During perimenopause, that metabolic support matters even more. Menoplus includes both alongside the botanical ingredients specifically chosen for the perimenopausal transition — Sage for hot flushes, Red Clover isoflavones for oestrogen balance, Hops for sleep and anxiety, Shatavari and Maca for energy and mood, and active B vitamins for nervous system support.

It's designed so you don't have to choose between PCOS support and perimenopause support.

👉 See the full Menoplus formulation →

5. Protect your sleep. Sleep disruption is often one of the earliest perimenopausal signs — and it directly impairs insulin sensitivity and cortisol regulation the following day. Addressing sleep before it deteriorates is one of the highest-leverage steps you can take right now.

6. Manage your stress load deliberately. Cortisol dysregulation is already common in PCOS. In perimenopause, as oestrogen declines and the adrenal glands take on more hormonal responsibility, stress management moves from nice-to-have to non-negotiable. This is not about self-care rituals. It is about sustainable workload, adequate recovery, and protecting the nervous system that's carrying a significant hormonal burden.

Yes — women with PCOS tend to enter menopause approximately two years later than women without it, likely due to greater ovarian reserve from higher antral follicle counts.

A 2026 Finnish cohort study found that women with PCOS were significantly less likely to have entered late perimenopause or postmenopause by age 46 — just 3.1% compared to 18.4% of women without PCOS. The same study found women with PCOS had 32% lower odds of experiencing any menopausal symptoms at that age, with 41% lower odds of hot flushes specifically.

The higher antral follicle count characteristic of PCOS — those immature follicles that are a defining feature of the condition — appears to confer a degree of ovarian reserve that delays menopausal transition, with the researchers noting this likely reflects longer natural oestrogen exposure.

What this means practically: if you have PCOS and are in your mid-40s with changing cycles, you may be earlier in perimenopause than peers without PCOS, or still in your late reproductive years with PCOS-related cycle variation. The distinction matters for how you interpret symptoms and what conversations to have with your doctor.

The research here is still developing. What is clear is that the perimenopausal timeline in PCOS does not follow standard population patterns — and clinical care should reflect that.

PCOS evolves from a reproductive condition in younger years to a predominantly metabolic condition by midlife — and navigating this transition well requires understanding that shift, not waiting for the condition to disappear.

If there is one reframe that changes everything: stop waiting for PCOS to be over. It won't be. But it will change. And the version of PCOS that requires your attention in your 40s is not the version that kept you up at night in your 20s.

The reproductive anxiety eases. The metabolic picture asks for more strategic, proactive attention.

Women who navigate this life stage with confidence are not the ones who had the smoothest hormonal journey — they are the ones who understood what was happening in their body, got the right tests, had honest conversations with their care providers, and built sustainable habits that compound over time.

Hormonal literacy isn't complicated — it's just rarely taught.

And you deserve to have it.

No. PCOS is a lifelong condition. While reproductive features like irregular cycles and elevated androgens often improve with age, the underlying metabolic components — particularly insulin resistance — persist into and beyond menopause. Long-term monitoring of metabolic markers remains important throughout life.

If you are in your late 30s to early 40s and noticing changes in your cycles, energy, mood, or metabolic patterns, MenoPlus may be worth exploring. The Myo-Inositol and D-Chiro Inositol it contains are among the most researched nutrients for PCOS metabolic support at any life stage, and the botanical ingredients support hormonal balance during the transition period. Speak with a healthcare provider if you are unsure what is right for your specific situation.

Beyond standard perimenopausal panels (FSH, LH, oestradiol), ask specifically for fasting insulin, HbA1c, full lipid panel, and total and free testosterone. These give you the metabolic picture that standard hormone panels miss — and they are the markers most directly relevant to PCOS long-term health.

This is expected. Research shows that menstrual cycle regularity tends to improve in women with PCOS as they approach perimenopause, as androgen levels decline and the ovarian picture shifts. This does not mean PCOS has resolved — it means the reproductive features are less pronounced while the metabolic features remain relevant and worth monitoring.

Yes. Oestrogen plays a protective role in insulin sensitivity. As oestrogen declines and fluctuates in perimenopause, insulin resistance can worsen — particularly in women who already had insulin resistance from PCOS. This is why metabolic monitoring and targeted support become more, not less, important in this life stage.

I was diagnosed with PCOS at 19 and handed almost nothing alongside it. No roadmap. No explanation of what it would mean for my body at 25, at 35, at 45. Just a diagnosis and a door.

It took years of my own research — and, honestly, years of loss — before I understood what PCOS actually was doing inside my body. By the time I built MyOva, I had lived through six miscarriages, the terror of believing my body was working against me, and the slow, hard work of rebuilding trust in it again. That journey is what made me determined to create products that address what's actually happening hormonally — not just the surface symptoms, but the root of them.

What I know now, and what I wish I had known far earlier, is this: PCOS does not stay the same. The condition you managed in your 20s is not the condition asking for your attention in your 40s. And the transition into perimenopause is one of the most important — and most overlooked — chapters in the PCOS story.

When I was developing Menoplus, I kept coming back to the women in our community who were telling us the same thing: I still have PCOS, but now my body is doing something completely different, and I don't know what to do with that. They weren't being dramatic. They were describing a real physiological shift that medicine rarely explains and products rarely address.

That's the gap Menoplus was built to fill.

If you're in your 40s and something feels different — harder, more layered, less predictable than before — I want you to know that you're not imagining it, and you're not alone. Your body is asking for a different kind of support right now. And there is so much you can do.

You've already proven you're the kind of woman who figures things out. This chapter is no different.

— Leila, Founder of MyOva